Ani Pharmaceuticals (ANIP) Tax Rate (2012 - 2026)
Ani Pharmaceuticals (ANIP) reported Tax Rate of 26.68% for Q1 2026, up 516.0% on a YoY basis from 4.33% in Q1 2025, and up 112.37% sequentially from 12.56% in Q4 2025.
Ani Pharmaceuticals (ANIP) Tax Rate (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 15 years of Tax Rate data on file, last reported at 26.68% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate rose 516.0% year-over-year to 26.68%; the trailing twelve-month figure through Mar 2026 stood at 20.57% (down 298.0% YoY), and the FY2025 full-year result was 18.22%, up 161.0% from the prior year.
- Tax Rate improved to 26.68% in Q1 2026, from 12.56% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 32.33% in Q1 2023 to a low of 21.86% in Q4 2023.
- A 5-year average of 17.59% and a median of 21.95% in 2022 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate tumbled 4762 bps in 2023 and soared 4722 bps in 2024, its largest moves.
- Tracing ANIP's Tax Rate over 5 years: stood at 25.76% in 2022, then tumbled by 185 bps to 21.86% in 2023, then jumped by 216 bps to 25.36% in 2024, then plunged by 50 bps to 12.56% in 2025, then soared by 112 bps to 26.68% in 2026.
- Business Quant data shows ANIP's Tax Rate at 26.68% in Q1 2026, 12.56% in Q4 2025, and 21.25% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 15.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.71% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -23.33% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 13.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 171.33% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 19.81% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 34.48% |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | 26.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.68% |
| Mar 31, 2026 | 26.68% |
| Mar 31, 2026 | 26.68% |
| Dec 31, 2025 | 12.56% |
| Dec 31, 2025 | 12.56% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 21.25% |
| Sep 30, 2025 | 21.25% |
| Sep 30, 2025 | 21.25% |
| Jun 30, 2025 | 19.00% |
| Jun 30, 2025 | 19.00% |
| Jun 30, 2025 | 19.00% |
| Mar 31, 2025 | 21.51% |
| Mar 31, 2025 | 21.51% |
| Mar 31, 2025 | 21.51% |
| Dec 31, 2024 | 25.36% |
| Dec 31, 2024 | 25.36% |
| Dec 31, 2024 | 25.36% |
| Sep 30, 2024 | 23.18% |
| Sep 30, 2024 | 23.18% |